E. TANHEHCO ET AL.: "The anti-factor D antibody, MAb 166-32, inhibits the alternative pathway of the human complement system." TRANSPLANTATION PROCEEDINGS, vol. 31, no. 5, August 1999 (1999-08), pages 2168-2171, XP002454359 New York, NY, USA (B1)

HARBOE M ET AL: "The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation", CLINICAL AND EXPERIMENTAL IMMUNOLOGY, WILEY-BLACKWELL PUBLISHING LTD, GB, vol. 138, no. 3, 1 December 2004 (2004-12-01), pages 439-446, XP002454358, ISSN: 0009-9104, DOI: 10.1111/J.1365-2249.2004.02627.X (B1)

K. PETRUKHIN: "New therapeutic targets in atrophic age-related macular degeneration." EXPERT OPINION ON THERAPEUTIC TARGETS, vol. 11, no. 5, May 2007 (2007-05), pages 625-639, XP008094820 GB (B1)

M. HARBOE ET AL.: "The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation." CLINICAL AND EXPERIMENTAL IMMUNOLOGY, vol. 138, no. 3, December 2004 (2004-12), pages 439-446, XP002454358 GB (B1)

Ü. AKIF ET AL.: "Novel anti-factor D monoclonal antibody inhibits complement and leukocyte activation in a baboon model of cardiopulmonary bypass." THE ANNALS OF THORACIC SURGERY, vol. 74, no. 2, August 2002 (2002-08), pages 355-362, XP002490167 USA (B1)

WO-A-2006/042329 (B1)

WO-A-2007/056227 (B1)

WO-A-99/42133 (B1)

P. BORA ET AL.: "Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization." THE JOURNAL OF IMMUNOLOGY, vol. 174, no. 1, 1 January 2005 (2005-01-01), pages 491-497, XP002456229 Baltimore, MD, USA (B1)